HMOX1 and COVID-19: Furthermore, statins may upregulate HO-1 [7], which is a central modulator of the immune system, affecting anti-inflammation and anti-oxidation, which could prevent the severe “cytokine storm” inflammatory response that is central to morbidity and mortality in COVID-19 patients [48].